Activist investor Starboard Value has announced a significant $1 billion investment in Pfizer, aiming to spur a turnaround within the pharmaceutical giant. The firm, known for its aggressive investment strategies, has reportedly engaged former executives to assist in its efforts. This move signals Starboard's intent to influence Pfizer's strategic direction as it seeks to enhance shareholder value.